Teva Pharmaceutical Industries Ltd. (TEVA) is poised to receive conditional clearance from the European Union for its almost $7 billion takeover of U.S. specialty drugmaker Cephalon Inc. (CEPH), Reuters reported Monday citing a person with direct knowledge of the matter.

The EU executive, which is scheduled to decide by Oct. 13 whether to clear the acquisition, wasn't immediately available for comment, Reuters said.

Full story at http://www.reuters.com/article/2011/10/10/us-cephalon-teva-eu-idUSTRE7993OH20111010

-Dow Jones Newswires; 212-416-2900

Cephalon (NASDAQ:CEPH)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Cephalon Charts.
Cephalon (NASDAQ:CEPH)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Cephalon Charts.